HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expanded Poly(tetrafluoroethylene) Blood Vessel Grafts with Embedded Reactive Oxygen Species (ROS)-Responsive Antithrombogenic Drug for Elimination of Thrombosis.

Abstract
Treatment of cardiovascular diseases suffers from the lack of transplantable small-diameter blood vessel (SDBV) grafts that can prohibit/eliminate thrombosis. Although expanded poly(tetrafluoroethylene) (ePTFE) has the potential to be used for SDBV grafts, recurrence of thrombus remains the biggest challenge. In this study, a reactive oxygen species (ROS)-responsive antithrombogenic drug synthesis and a bulk coating process were employed to fabricate functional ePTFE grafts capable of prohibiting/eliminating blood clots. The synthesized drug that would release antiplatelet ethyl salicylate (ESA), in responding to ROS, was dissolved in a polycaprolactone (PCL) solution, followed by a bulk coating of the as-fabricated ePTFE grafts with the PCL/drug solution. Nuclear magnetic resonance (NMR) spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM), and atomic force microscopy (AFM) were employed to investigate and confirm the synthesis and presence of the ROS-responsive drug in the ePTFE grafts. The ESA release functions were demonstrated via the drug-release profile and dynamic anticoagulation tests. The biocompatibility of the ROS-responsive ePTFE grafts was demonstrated via lactate dehydrogenase (LDH) cytotoxicity assays, live and dead cell assays, cell morphology, and cell-graft interactions. The ROS-responsive, antithrombogenic ePTFE grafts provide a feasible way for maintaining long-term patency, potentially solving a critical challenge in SDBV applications.
AuthorsDongfang Wang, Yiyang Xu, Lixia Wang, Xiaofeng Wang, Cuihong Ren, Bo Zhang, Qian Li, James A Thomson, Lih-Sheng Turng
JournalACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 12 Issue 26 Pg. 29844-29853 (Jul 01 2020) ISSN: 1944-8252 [Electronic] United States
PMID32496045 (Publication Type: Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Fluorocarbons
  • Polyesters
  • Polymers
  • Reactive Oxygen Species
  • Salicylates
  • polycaprolactone
  • ethyl salicylate
  • Polytetrafluoroethylene
  • L-Lactate Dehydrogenase
  • tetrafluoroethylene
Topics
  • Animals
  • Fibrinolytic Agents (therapeutic use)
  • Fluorocarbons (chemistry)
  • Humans
  • L-Lactate Dehydrogenase (metabolism)
  • Magnetic Resonance Spectroscopy
  • Microscopy, Atomic Force
  • Polyesters (chemistry)
  • Polymers (chemistry)
  • Polytetrafluoroethylene (chemistry)
  • Reactive Oxygen Species (metabolism)
  • Salicylates (chemistry)
  • Spectroscopy, Fourier Transform Infrared
  • Thrombosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: